NCT03682770 · Interventional trial
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
Overall registry status Completed
Phase 2
Conditions Peanut Allergy
Delaware Valley sites
- Regeneron Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory